NLS Pharmaceutics Enhances CNS Research with AEX-6xx Drug Series Development NLS Pharmaceutics introduces the AEX-6xx series, enhancing its CNS research with novel compounds aimed at treating neurodegenerative disorders and cognition.

NLS Pharmaceutics Enhances CNS Research with AEX-6xx Drug Series Development #Switzerland #NLS_Pharmaceutics #Zurich #CNS_Therapy #Aexon_Labs

Swixx BioPharma Partners with Lundbeck to Expand CNS Therapy Market Access Swixx BioPharma has entered a strategic partnership with Lundbeck, enhancing CNS treatment accessibility across three regions. This transformative deal aims to optimize patient access and expand Lundbeck's product reach.

Swixx BioPharma Partners with Lundbeck to Expand CNS Therapy Market Access #Switzerland #Lundbeck #Baar #Swixx_BioPharma #CNS_Therapy